[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345509-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345509-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-omics-and-pan-cancer-analysis-revealed-common-molecular-signatures-to-disclose-multitargeted-anticancer-agents-through-network-pharmacology-approach","Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach","","Cancer is a multifactorial disease driven by complex genetic and molecular mechanisms that often converge across tissue types. Shared oncogenic pathways can improve understanding of common functions and support discovery of broad-spectrum therapeutics. This study integrated three transcriptomic datasets to define common differentially expressed genes between breast, ovarian, and colorectal cancers, and built PPI, enrichment, and regulatory networks to infer multitargetable processes and drug targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-omics-and-pan-cancer-analysis-revealed-common-molecular-signatures-to-disclose-multitargeted-anticancer-agents-through-network-pharmacology-approach/345509/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-omics-and-pan-cancer-analysis-revealed-common-molecular-signatures-to-disclose-multitargeted-anticancer-agents-through-network-pharmacology-approach/345509.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cancers were compared to identify common oncogenic pathways in this study?","Question",{"text":63,"@type":64},"The study focused on breast, ovarian, and colorectal (BOC) cancers to find shared oncogenic pathways and common molecular signatures.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were common differentially expressed genes identified?",{"text":68,"@type":64},"Three transcriptomic datasets were analyzed to detect common differentially expressed genes (DEGs) across the compared cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"What targets and computational approaches supported the multitargeted anticancer strategy?",{"text":72,"@type":64},"Protein-protein interaction analysis highlighted hub targets (including AURKA, CDK1, and CCNB1), while GO/KEGG enrichment, regulatory network analyses, molecular docking, molecular dynamics, and MM-GBSA supported the multitargeting hypothesis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345509,1790347693,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nCitation: Sarker H, Farid FB, Kamrun M, Masud E, Ahmed A, Miah M, et al. (2026) Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach. PLoS One 21(6): e0350614. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0350614](journal.pone.0350614)  \nEditor: Chandrabose Selvaraj, AMET University, INDIA  \nReceived: January 12, 2026  \nAccepted: May 14, 2026  \nPublished: June 1, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0350614  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon,  \nRESEARCH ARTICLE  \nMulti-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach  \nHriddhi Sarker1,2, Farhad Bin Farid1,3, Marguba Kamrun1,4, Esha Masud1,5,  \nAsif Ahmed1,5, Mamun Miah1,6, Neladre Shaker Roy1, Neeraj Kumar7, Md Ahad Ali1,8*  \n1 Department of Computational Chemistry and Drug Design, Panacea Research Center, Rajshahi, Bangladesh, 2 Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh, 3 Department of Pharmacy, University of Development Alternative (UODA), Dhaka, Bangladesh, 4 Department of Chemistry and Biochemistry, University of Oklahoma Norman, Norman, Oklahoma, United States of America, 5 Department of Pharmacy, Khwaja Yunus Ali University, Sirajganj, Bangladesh, 6 Department of Pharmacy, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh, 7 Department of Pharmaceutical Chemistry, Bhupal Nobles’ College of Pharmacy, Udaipur, Rajasthan, India, 8 Department of Chemistry, University of Rajshahi, Rajshahi, Bangladesh  \n* [ahad.chembd@gmail.com](ahad.chembd@gmail.com)  \nAbstract  \nCancer is characterized as a multifactorial disease due to their complex genetic and molecular mechanisms that often converge across tissue types. Shared oncogenic pathways can help us understand these functions and discover broad-spectrum therapeutics. Earlier, most studies focused on finding specific drivers for individual cancer types. However, researchers are now more interested in identifying common molecular patterns across different cancers and developing therapies that can target multiple pathways at once. This study aimed to understand the common oncogenic pathways between breast, ovarian and colorectal (BOC) cancers and identify possible multitargeted therapeutic drug molecules. To identify the common differentially expressed genes (DEGs), we analyzed three transcriptomic datasets and found a total of 128 DEGs. The protein-protein interaction (PPI) network study reveals the top-ranked, most significant hub targets, AURKA, CDK1 and CCNB1, as drug targets. Enrichment analysis with GO and KEGG pathways, as well as regulatory network (TFs and mRNAs) analysis, revealed common pathogenetic processes among BOC cancers. The AMG-900 exhibits the highest binding affinity scores of −10 .8, −9 .40, and −9.7 kcal/mol with the target proteins AURKA, CCNB1, and CDK1, respectively. The stability and structural flexibility of the selected protein-ligand complexes were validated by a large-scale (500 ns) molecular dynamics and MM-GBSA analyses, and the results indicate stable interactions for AURKA and CCNB1, while CDK1 showed comparatively reduced stability. The pharmacokinetic analysis revealed favor  \nable drug-likeness and a manageable toxicity profile typical of anticancer agents.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0350614](https://doi.org/","cbCaib1VyF0p22sS","https://ap.wps.com/l/cbCaib1VyF0p22sS","pdf",4502112,32,"English","# Abstract\n# Introduction","[{\"question\":\"Which cancers were compared to identify common oncogenic pathways in this study?\",\"answer\":\"The study focused on breast, ovarian, and colorectal (BOC) cancers to find shared oncogenic pathways and common molecular signatures.\"},{\"question\":\"How were common differentially expressed genes identified?\",\"answer\":\"Three transcriptomic datasets were analyzed to detect common differentially expressed genes (DEGs) across the compared cancers.\"},{\"question\":\"What targets and computational approaches supported the multitargeted anticancer strategy?\",\"answer\":\"Protein-protein interaction analysis highlighted hub targets (including AURKA, CDK1, and CCNB1), while GO/KEGG enrichment, regulatory network analyses, molecular docking, molecular dynamics, and MM-GBSA supported the multitargeting hypothesis.\"}]","Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach | PDF",1790057924,81,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5275b5fe6b57385487c8caa929b91ea1.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cffdc55830e41844284648d09ae1fa6.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59c17a12f5fdc180cdffdb84501edbcc.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/505fbfa6b37c154b980c09d3e62be943.webp",980,1268]